Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
Status:
Completed
Trial end date:
2019-03-20
Target enrollment:
Participant gender:
Summary
To determine the effect of re-activation of brain glucose metabolism induced by
dichloroacetate (DCA) on cognitive function and counterregulatory hormone responses in
patients with type 1 diabetes (T1DM) with recurrent hypoglycemia.